Biotech firm Definium Therapeutics appoints seasoned commercial executive Roger Adsett to its board, signaling a strategic shift towards commercialization as key late-stage trial data approaches.
Greenlight Capital has spotlighted Core Natural Resources (CNR), the entity formed from the merger of Arch Resources and CONSOL Energy, as a key coal investment. The fund cites the company's valuation and combined asset base, even as the sector grapples with operational challenges. This endorsement brings renewed scrutiny to CNR's integration path and its strategy in a complex market.
After a powerful 41% surge over the past year, Lattice Semiconductor (LSCC) finds itself at a crossroads. With shares trading near $80, new analysis suggests the stock may be significantly overvalued, raising questions about its long-term prospects in the competitive semiconductor landscape.
Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...
RH shares have slumped roughly 13% over the past week, contrasting sharply with strong gains over the prior month. This pullback places the luxury home furnishings retailer under a valuation microscope, with analysts debating whether the dip presents a buying opportunity or signals deeper challenges ahead.
USA Rare Earth secures a landmark $1.6 billion in federal loans and equity, coupled with a $1.5 billion private placement, to build a domestic supply chain from Texas mines to Oklahoma magnets, reducing reliance on China for critical defense and green tech components.
Vertiv Holdings Co launches 'Vertiv Next Predict,' an AI-driven managed service aimed at transforming data center maintenance through predictive analytics, signaling a strategic shift towards high-margin, recurring revenue streams.
Shares of Deckers Outdoor Corp. surged nearly 20% following a robust quarterly report and an optimistic fiscal 2026 outlook, driven by exceptional performance from its UGG and HOKA footwear brands.
Disney's iconic leader, who returned to steady the company in 2022, is reportedly preparing to exit the CEO role ahead of his contract's expiration, setting the stage for a high-stakes succession search.
Boeing's Wichita-based engineering union has overwhelmingly approved a new labor agreement, securing substantial pay raises and improved benefits for approximately 1,600 technical staff, many recently transitioned from Spirit AeroSystems.
SanDisk Corporation's stock hit an all-time peak following a blockbuster earnings report for Q2 FY2026, fueled by surging demand for its storage solutions from the artificial intelligence sector.
Shares of Colgate-Palmolive jumped over 6% as the consumer goods giant outlined a resilient growth plan through 2026, even after reporting a significant profit decline in a tough operating climate.
Victoria's Secret shares have surged nearly 50% in the past year, leaving investors to grapple with a critical question: Is the rally justified, or has the market gotten ahead of itself? A deep dive into the numbers reveals a complex picture where traditional valuation models clash.
Subsea 7 secures a significant contract from Shell for the Kaikias Waterflood project, reinforcing its position in complex deepwater engineering and extending its project visibility in the US Gulf of Mexico.
Fair Isaac Corporation (FICO), the analytics software giant behind the ubiquitous credit score, has seen its shares retreat from multi-year highs. This pullback has investors debating whether the dip presents a rare entry point or signals that the stock's premium valuation is finally facing a reality check.
AerCap Holdings' stock has soared over 50% in the past year, but recent trading shows momentum stalling. With shares trading below a key fair value estimate, investors are weighing whether the market has already priced in the recovery or if there's still room to climb.
After a bruising year that saw its shares tumble by a third, biotech giant CSL is back in the spotlight. We delve beyond the headline numbers, examining valuation models and market sentiment to assess if the sell-off has created a compelling entry point for long-term investors.
In a strategic push beyond traditional lending, Ares Management has seized operational control of a multi-club football group and orchestrated a $1.6 billion financing to create a new global personal care platform, Evermark. The moves signal the firm's aggressive expansion into high-profile, control-oriented credit opportunities.
Barclays' stock has delivered a stellar 68% total return to shareholders over the past year, fueled by strong revenue and profit figures. As the share price approaches analyst targets, investors are weighing whether the current valuation still offers value or if the easy gains have been made.
Franklin Resources, Inc. (NYSE: BEN) saw its shares climb over 5% following a better-than-expected fiscal Q1 2026 report and the unveiling of its AI-powered 'Intelligence Hub', developed in partnership with Microsoft, signaling a push towards operational modernization.
